… immunologic biomarkers and their associations with severity and outcomes of COVID-19. …
In this study, longitudinal variations in hematologic and immunologic biomarkers associated …

… In this study we aimed to evaluate the discriminative ability of hematologic, biochemical
and immunologic biomarkers in patients with and without the severe or fatal forms of COVID-19. …

… The COVID-19 pandemic has posed a great challenge to the medical community because
… This review focuses on immune biomarkers that can be measured in peripheral blood in a …

… Coronavirus disease 19 (COVID-19) is a pandemic caused … coronavirus 2 (SARS-CoV-2,
also referred as hCoV-19) with … COVID-19 and reported in previous COVID-19 omics datasets. …

… In COVID-19, … in COVID-19 patients might lead to T-cell exhaustion or activation. This
review summarizes the available studies that investigated IC receptors and ligands in COVID-19 …

… prognosis and management of COVID-19 patients. Of utmost … The role of biomarkers such
as IL-6, procalcitonin, neutrophil… in potential biomarkers for COVID-19 severity and persistence…

… biomarkers in COVID-19, while Figure 1 depicts possible multiorgan involvement in COVID-19…
affected by severe COVID-19, associated laboratory and clinical biomarkers of damage, …

… immunoassays in adult and pediatric COVID-19 patients, as well as the … immunological
disorders and diseases, it is challenging to interpret the multiplex cytokine data for COVID-19 …

… relationship between COVID-19 disease and the levels of these tests by comparing the AAT,
AGP, Total IgM, Total IgG, Gal3, and SARS-CoV-2 IgG levels in patients with COVID-19 and …

… In this respect, we might speculate the potential role of procalcitonin as a prognostic
biomarker during the severe status of COVID-19. Finally, our team revealed increased levels of …